Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Bayer wins EU approval for $62.5 billion Monsanto buy

Published 03/21/2018, 02:29 PM
Updated 03/21/2018, 02:29 PM
© Reuters. EU Competition Commissioner Vestager holds a news conference in Brussels

By Foo Yun Chee

BRUSSELS (Reuters) - German conglomerate Bayer (DE:BAYGN) won EU antitrust approval on Wednesday for its $62.5 billion buy of U.S. peer Monsanto (NYSE:MON), the latest in a trio of mega mergers that will reshape the agrochemicals industry.

The tie-up is set to create a company with control of more than a quarter of the world's seed and pesticides market.

Driven by shifting weather patterns, competition in grain exports and a faltering global farm economy, Dow and Dupont, and ChemChina and Syngenta had earlier led a wave of consolidation in the sector.

Both deals secured EU approval only after the companies offered substantial asset sales to boost rivals.

Environmental and farming groups have opposed all three deals, worried about their power and their advantage in digital farming data, which can tell farmers how and when to till, sow, spray, fertilize and pick crops based on algorithms.

The European Commission said Bayer addressed its concerns with its offer to sell a swathe of assets to boost rival BASF, confirming a Reuters story on Feb. 28.

"Our decision ensures that there will be effective competition and innovation in seeds, pesticides and digital agriculture markets also after this merger," European Competition Commissioner Margrethe Vestager said in a statement.

"In particular, we have made sure that the number of global players actively competing in these markets stays the same."

Vestager said the Commission, which received more than a million petitions concerning the deal, had been thorough by examining more than 2,000 different product markets and 2.7 million internal documents to produce a 1,285-page ruling.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The U.S. Justice Department, which is also reviewing the merger, said in a statement on its website that it would press on with its review and that the market in the two regions was quite different.

"While genetically modified seeds are largely prohibited in Europe, they are widely used throughout the United States," the department noted. "The Antitrust Division of the Department of Justice continues to examine the effects of the proposed transaction on American farmers and consumers."

China has given conditional approval to the Bayer and Monsanto deal, which has won a green light in Brazil. It is currently being reviewed by Russian antitrust authorities too.

Bayer has already reached a deal to sell certain seed and herbicide assets for 5.9 billion euros ($7.2 billion) to BASF and to give it a license to its global digital farming data. It will also divest its vegetable seeds business to BASF.

The Commission is due to rule on the BASF deal by April 16.

Online campaigns group Avaaz criticized the EU approval.

"This is a marriage made in hell. The Commission ignored a million people who called on them to block this deal, and caved in to lobbying to create a mega-corporation which will dominate our food supply," Avaaz legal director Nick Flynn said.

U.S.-incorporated Avaaz, funded by its members, is active in climate change, poverty, conflict and corruption issues.

The Greens grouping in the European Parliament echoed the sentiment, saying smaller players in the agriculture industry needed to be helped too.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"The agriculture industry is already far too concentrated, giving a handful of massive firms a stranglehold on food production. Merging two of the biggest players only makes a bad situation worse," Greens spokesman Bart Staes said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.